{"doi":"10.1172/jci200420986","title":"Central role of the P2Y12 receptor in platelet activation","abstract":null,"journal":null,"year":null,"id":593152,"datarank":2.374896544128733,"base_score":3.9512437185814275,"endowment":3.9512437185814275,"self_citation_contribution":0.5926865577872142,"citation_network_contribution":1.7822099863415186,"self_endowment_contribution":0.5926865577872142,"citer_contribution":1.7822099863415186,"corpus_percentile":null,"corpus_rank":null,"citation_count":51,"citer_count":51,"citers_with_citation_signal":39,"citers_with_endowment":39,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Central role of the P2Y12 receptor in platelet activation","abstract":"Platelet activation occurs in response to vessel injury and is important for the arrest of bleeding. Platelet activation during disease states leads to vascular occlusion and ischemic damage. The P2Y 12 receptor, activated by ADP, plays a central role in platelet activation and is the target of P2Y 12 receptor antagonists that have proven therapeutic value.","is_dataset_classified":null,"base_score":3.9512437185814275,"endowment":3.9512437185814275,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"14755328","pmcid":"PMC324551","openalex_id":"https://openalex.org/W4236157348","authors":[],"funders":[],"total_grants":0,"fwci":1.2402,"citation_percentile":0.81043321,"influential_citations":0,"citation_trend":[{"year":2012,"count":8},{"year":2013,"count":2},{"year":2015,"count":3},{"year":2017,"count":2},{"year":2018,"count":6},{"year":2019,"count":1},{"year":2020,"count":1},{"year":2021,"count":2},{"year":2022,"count":2},{"year":2024,"count":2},{"year":2025,"count":1},{"year":2026,"count":1}],"oa_status":"bronze","license":null,"oa_locations":[{"url":"http://www.jci.org/articles/view/20986/files/pdf","host_type":"journal"},{"url":"http://www.jci.org/articles/view/20986/files/pdf","host_type":"publisher"},{"url":"https://doi.org/10.1172/jci200420986","host_type":"journal"},{"url":"http://doi.org/10.1172/JCI200420986","host_type":"repository"}],"fields_of_study":["Antiplatelet Therapy and Cardiovascular Diseases","Venous Thromboembolism Diagnosis and Management","Platelet Disorders and Treatments"],"mesh_terms":["Blood Platelets","Humans","Membrane Proteins","Receptors, Purinergic P2","Adenosine Diphosphate","Bleeding Time","Blood Coagulation","Platelet Activation","Receptors, Purinergic P2Y12"],"keywords":["P2Y12","Platelet activation","Platelet","Receptor","Medicine","Chemistry","Internal medicine","Pharmacology","Platelet aggregation"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-26T17:29:36.788755Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}